AbClon Inc. (KOSDAQ:174900)
South Korea · Delayed Price · Currency is KRW 18,330
-140 (-0.76%)
Nov 2, 2026, 3:30 PM KST
AbClon Market Cap
AbClon has a market cap or net worth of 365.72 billion as of October 30, 2026. It is the 18,502nd most valuable company in the world and the 538th biggest in South Korea. Its market cap has decreased by 11.73% in one year.
Market Cap
365.72B
Enterprise Value
337.08B
Revenue
5.31B
Global Rank
Country Rank
#538 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since September 18, 2017, AbClon's market cap has increased from 176.80B to 365.72B, an increase of 106.86%. That is a compound annual growth rate of 8.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 365.72B | -54.98% |
| Dec 30, 2025 | 812.27B | 230.14% |
| Dec 30, 2024 | 246.04B | 6.90% |
| Dec 28, 2023 | 230.16B | 17.39% |
| Dec 29, 2022 | 196.07B | -27.49% |
| Dec 30, 2021 | 270.42B | -48.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharmicell | 571.84B |
| Onconic Therapeutics | 563.51B |
| Proteina | 540.73B |
| Hyundai Bioscience | 527.87B |
| GI Innovation | 430.32B |
| GC Corp. | 423.51B |
| Medy-Tox | 413.33B |
| Orum Therapeutics | 331.73B |